AI Medical Service

AI Medical ServiceAI Medical Service
AM

AI Medical Service

An artificial intelligence and healthcare company making software for the early detection of gastrointestinal cancers.

DR 02017InactiveTokyo, Japan
Rate

About

AI Medical Service Inc. (AIM) is a Japanese med-tech company focused on developing AI-powered software for the early detection of gastrointestinal cancers. Their technology analyzes endoscopic images to assist physicians in identifying cancerous lesions, aiming to reduce missed diagnoses and improve patient outcomes globally.
Frequently asked

What does AI Medical Service do?

AI Medical Service Inc. (AIM) is a Japanese med-tech company focused on developing AI-powered software for the early detection of gastrointestinal cancers. Their technology analyzes endoscopic images to assist physicians in identifying cancerous lesions, aiming to reduce missed diagnoses and improve patient outcomes globally.

What is AI Medical Service's valuation?

StartupHub estimates AI Medical Service's effective valuation at $492.5M (range $304.8M to $731.4M, 10% confidence), based on comparable companies in the sector.

How much funding has AI Medical Service raised?

AI Medical Service has raised a total of $122M in funding. The most recent round on record is Series C.

Where is AI Medical Service headquartered?

AI Medical Service is headquartered in Tokyo, Japan.

When was AI Medical Service founded?

AI Medical Service was founded in 2017.

What is AI Medical Service's current status?

AI Medical Service's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.